S&P 500
7,633.20
+0.31%
Dow Jones
53,893.00
+1.14%
Nasdaq 100
29,106.20
+0.99%
Russell 2000
2,995.41
+0.37%
FTSE 100
10,904.40
+0.20%
Nikkei 225
64,309.90
+1.28%

Investing

LEGN logo Legend Biotech : LEGN

Price Target $64 ↑211.9%
›

LEGN

Stock Data

$20.75

Change up

$1.47 (7.62%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Legend Biotech Corp is a pioneering biopharmaceutical company focused on creating innovative cell therapies for cancer and other serious diseases. With a leading product candidate aimed at treating multiple myeloma, Legend Biotech is at the forefront of developing chimeric antigen receptor (CAR) T-cell therapies. Their research spans a range of cancers, including leukemia, lymphoma, and various solid tumors. Founded in 2014 and headquartered in Somerset, New Jersey, the company collaborates with Janssen Biotech to advance the reach and effectiveness of its groundbreaking treatments.

Latest Activity

LEGNLegend Biotech Corporation
Reports Tue Aug 11Before open7:00 AM ETConfirmed

Legend Biotech reports at 7:00 AM ET, and the only question that matters is whether Carvykti's growth is still outpacing J&J's Tecvayli with anito-cel's launch closing in. Manufacturing capacity commentary moves this $4 billion stock as much as the numbers do.

    Read more

    All Legend Biotech Articles

    3 Articles